2016 Q1/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +6 Neurocrine Biosciences
7.7
2 +8 Wockhardt
7.5
3 +2 Galenica AG
7.4
4 +8 Taisho Pharmaceutical
7.1
5 -1 Kyorin Holdings
7.0
6 -4 ProStrakan Group
7.0
7 -6 Anika Therapeutics
6.9
8 -5 Actelion
6.8
9 +41 MediGene
6.8
10 -1 Alfa Wassermann
6.8
11 +0 Kaken Pharmaceutical
6.7
12 +15 Nissan Chemical
6.5
13 +0 Bavarian Nordic
6.4
14 +0 Mitsubishi Tanabe Pharma Europe Ltd
6.3
15 +3 Meda Pharmaceuticals
6.3
16 -8 Yakult UK
6.3
17 +0 EISAI
6.1
18 +4 Lundbeck
6.1
19 +1 EISAI UK
6.0
20 +1 Genmab
5.9
21 -6 Debiopharm
5.9
22 -6 Zandu
5.8
23 +1 Daiichi-Sankyo UK
5.6
24 +14 United Therapeutics
5.5
25 +1 Servier
5.5
26 +17 Sawai Pharmaceutical
5.4
27 +8 Enzo Biochem
5.4
28 +3 Baxter International
5.4
29 -1 Pfizer UK
5.3
30 -11 Dainippon Sumitomo
5.3
31 -6 Forest
5.3
32 +16 Shire
5.2
33 +0 ViroPharma
5.2
34 +3 CinnaGen
5.2
35 -6 Astellas Europe
5.2
36 -13 Diffusion Pharmaceuticals
5.2
37 +16 Santen
5.1
38 -8 Takeda UK
5.1
39 +16 Covence
5.1
40 -8 Recordati
5.1
41 -5 Stallergenes UK
5.0
42 +0 Astrazeneca Uk
4.9
43 +8 Valeant Europe
4.9
44 -10 Otsuka Pharmaceuticals
4.9
45 +28 AEterna Zentaris
4.9
46 +14 Nippon Chemiphar
4.9
47 +0 Boehringer Ingelheim
4.9
48 +48 Toray Industries
4.8
49 +27 Biotest
4.8
50 -11 Ipsen UK
4.8


Changes in rank are compared to 2015 Q4/Global Life Sciences. Since then, 6 sites entered the survey and 43 sites could not be included in the rankings (1 more since last time). Build your own. Report statistics.